Dina Masi, Chief Financial Officer at Integrated Biopharma (OTC:INBP), reported a large exercise of company stock options on September 21, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Masi, Chief Financial Officer at Integrated Biopharma, a company in the Consumer Staples sector, just exercised stock options worth 50,000 shares of INBP stock with an exercise price of $0.09.
Integrated Biopharma shares are trading down 0.0% at $0.28 at the time of this writing on Thursday morning. Since the current price is $0.28, this makes Masi's 50,000 shares worth $14,025.